Financial institutions (Morgan Stanley, BofA, Norges Bank, Millennium Management) made various market moves and issued research notes regarding Acadia Pharmaceuticals.
1 report, 1 independent
Updated Sep 12
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Financial institutions (Morgan Stanley, BofA, Norges Bank, Millennium Management) made various market moves and issued research notes regarding Acadia Pharmaceuticals.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Morgan Stanley
U.S. investment bank
-
Acadia Pharmaceuticals
Pharmaceutical company, which developed Nuplazid, based in San Diego, California.
Nothing else this week.
-
Millennium Management
alternative investment management firm
- Millennium Management is establishing a presence in Athens, the capital of Greece, while Kyriakos Mitsotakis serves as Prime Minister and Kyriakos Pierrakakis discusses expansion.
- Millennium Management, specializing in Japanese government bonds, faced adverse strategy impacts due to yen rate volatility and filed regulatory records with the Monetary Authority of Singapore.
-
Bank of America
American multinational banking and financial services corporation
Related events
- Multiple financial institutions, including Morgan Stanley and Norges Bank, made significant moves regarding Assurant stock, alongside analyst rating changes and SEC filings.
- Morgan Stanley has released research reports concerning the company stock of Molson Coors Beverage Company.
- Morgan Stanley issued research reports and price targets, while institutional investment disclosures were filed with the SEC regarding a new stake purchase in Stanley Black & Decker.
- Citigroup and Morgan Stanley are noted as major financial services players.
- Millennium Management increased its stake in AbbVie and purchased shares of SpaceX stock on September 12, 2026.